| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,745 |
7,674 |
$299K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,685 |
5,046 |
$208K |
| 99215 |
Prolong outpt/office vis |
969 |
843 |
$53K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,028 |
1,786 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
330 |
282 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
384 |
311 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
326 |
272 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
726 |
357 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
121 |
104 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
571 |
497 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
778 |
616 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
115 |
101 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,778 |
1,374 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
242 |
214 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
220 |
189 |
$2K |
| 90688 |
|
226 |
207 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
32 |
31 |
$1K |
| 90674 |
|
68 |
59 |
$1K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
206 |
152 |
$986.39 |
| 87634 |
|
16 |
13 |
$725.31 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$389.19 |
| 82043 |
|
66 |
52 |
$252.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
225 |
171 |
$245.10 |
| 90756 |
|
17 |
14 |
$232.54 |
| G0008 |
Administration of influenza virus vaccine |
77 |
69 |
$179.90 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
21 |
16 |
$169.80 |
| 81003 |
|
482 |
364 |
$165.44 |
| 90686 |
|
21 |
17 |
$160.41 |
| 90658 |
|
16 |
15 |
$156.83 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
20 |
16 |
$156.61 |
| 99000 |
|
2,422 |
1,813 |
$151.61 |
| 90473 |
|
12 |
12 |
$92.55 |
| 1159F |
|
417 |
353 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
436 |
368 |
$0.00 |
| 1124F |
|
131 |
114 |
$0.00 |
| 90633 |
|
68 |
64 |
$0.00 |
| 1160F |
|
419 |
355 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
23 |
22 |
$0.00 |
| 90461 |
|
44 |
26 |
$0.00 |
| 1158F |
|
101 |
88 |
$0.00 |
| 90649 |
|
16 |
15 |
$0.00 |
| 3078F |
|
17 |
15 |
$0.00 |
| 1170F |
|
328 |
283 |
$0.00 |
| 1125F |
|
151 |
133 |
$0.00 |
| 1126F |
|
228 |
200 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
21 |
17 |
$0.00 |
| 3074F |
|
36 |
34 |
$0.00 |
| 90716 |
|
13 |
13 |
$0.00 |